Clemastine fumarate syrup

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Approval Status:

Approved March 1998

Specific Treatments:

allergic rhinitis

Find Related Trials for The Following Conditions

General Information

Clemastine Fumarate Syrup 0.5 mg/5 ml, a generic version of Novartis' Tavist Syrup, has been approved for the treatment of allergic rhinitis.